May 11-14, 2021
Join YUMAB´s team at this year’s PEGS Boston Virtual to get the latest data on YUMAB’s fully human antibody technology platform and learn more about the company’s potential in fully human antibody engineering.
Don’t miss the panel discussion “Novel and Next-Generation Approaches to COVID-19 Therapeutics” on May 11th at 10 a.m. GMT-4 (4 p.m. GMT+2), including the presentation “Novel Anti-SARS-CoV2 Antibody Therapy with Safety Design for Treatment of Moderate to Severe COVID-19” by YUMAB’s CEO Thomas Schirmann.
Arrange a meeting
Visit YUMAB’s virtual booth at the meeting, interact with the team and dowload infos to learn more about your options!
Let us take you there:
People attending from YUMAB: